HomeEGTX • STO
add
Egetis Therapeutics AB (publ)
Previous close
kr 5.00
Day range
kr 4.91 - kr 5.27
Year range
kr 3.03 - kr 7.07
Market cap
2.05B SEK
Avg Volume
846.00K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 17.90M | 65.74% |
Operating expense | 124.60M | 18.10% |
Net income | -119.70M | -8.33% |
Net profit margin | -668.72 | 34.64% |
Earnings per share | -0.30 | 0.00% |
EBITDA | -110.30M | -14.51% |
Effective tax rate | -0.34% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 215.80M | -38.52% |
Total assets | 639.10M | -19.34% |
Total liabilities | 300.40M | 0.33% |
Total equity | 338.70M | — |
Shares outstanding | 395.16M | — |
Price to book | 5.81 | — |
Return on assets | -48.78% | — |
Return on capital | -76.17% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -119.70M | -8.33% |
Cash from operations | -92.90M | -73.32% |
Cash from investing | — | — |
Cash from financing | 163.70M | -39.99% |
Net change in cash | 70.10M | -68.28% |
Free cash flow | -56.52M | -314.48% |
About
Founded
2006
Website
Employees
42
